These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21609389)

  • 1. Optimizing cardiac resynchronization therapy in advanced heart failure.
    Mullens W; Tang WH
    Congest Heart Fail; 2011; 17(3):147-51. PubMed ID: 21609389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A metric for evaluating the cardiac response to resynchronization therapy.
    Ge Y; Ruwald AC; Kutyifa V; McNitt S; Polonsky S; Klein H; Goldenberg I; Solomon SD; Foster E; Zareba W; Moss AJ
    Am J Cardiol; 2014 Apr; 113(8):1371-7. PubMed ID: 24607029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac Resynchronization Therapy MOdular REgistry: ECG and Rx predictors of response to cardiac resynchronization therapy (NCT01573091).
    Stabile G; Bertaglia E; Botto G; Isola F; Mascioli G; Pepi P; Caico SI; De Simone A; D'Onofrio A; Pecora D; Palmisano P; Maglia G; Arena G; Malacrida M; Padeletti L
    J Cardiovasc Med (Hagerstown); 2013 Dec; 14(12):886-93. PubMed ID: 24149063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac resynchronization therapy reduces T-wave alternans in patients with heart failure.
    Hua W; Chen K; Zhou X; Dai Y; Chen R; Wang J; Ding L; Liu Z; Feng T; Yu J; Cheng J; Liu C; Zhang S
    Europace; 2015 Feb; 17(2):281-8. PubMed ID: 25398405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing cardiac resynchronization therapy for congestive heart failure.
    Duggirala S; Lee BK
    Curr Probl Cardiol; 2013 Jun; 38(6):215-37. PubMed ID: 23664171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverse Remodeling Achieved by Combination Therapy With High-Dose Beta Blocker and Cardiac Resynchronization.
    Muraoka H; Imamura T; Kinugawa K
    Int Heart J; 2015; 56(4):462-5. PubMed ID: 26084461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (123)I-mIBG imaging predicts functional improvement and clinical outcome in patients with heart failure and CRT implantation.
    Curcio A; Cascini GL; De Rosa S; Pasceri E; Veneziano C; Cipullo S; Saccomanno M; Santarpia G; Cuda G; Indolfi C
    Int J Cardiol; 2016 Mar; 207():107-9. PubMed ID: 26797344
    [No Abstract]   [Full Text] [Related]  

  • 8. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
    Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling.
    Fröhlich G; Steffel J; Hürlimann D; Enseleit F; Lüscher TF; Ruschitzka F; Abraham WT; Holzmeister J
    Eur Heart J; 2010 Jun; 31(12):1477-85. PubMed ID: 20233792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term independent predictors of positive response to cardiac resynchronization therapy.
    Toniolo M; Zanotto G; Rossi A; Tomasi L; Prioli MA; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):301-7. PubMed ID: 22395028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).
    Sherazi S; Goldenberg I; Moss AJ; Solomon S; Kutyifa V; McNitt S; Shah AH; Huang DT; Aktas MK; Zareba W; Barsheshet A
    Am J Cardiol; 2014 Oct; 114(7):1053-8. PubMed ID: 25118116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of QRS morphology and duration on outcomes after cardiac resynchronization therapy: Results from the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT).
    Birnie DH; Ha A; Higginson L; Sidhu K; Green M; Philippon F; Thibault B; Wells G; Tang A
    Circ Heart Fail; 2013 Nov; 6(6):1190-8. PubMed ID: 23995437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between right ventricular function and cardiac resynchronization therapy: an analysis of the CARE-HF trial (Cardiac Resynchronization-Heart Failure).
    Damy T; Ghio S; Rigby AS; Hittinger L; Jacobs S; Leyva F; Delgado JF; Daubert JC; Gras D; Tavazzi L; Cleland JG
    J Am Coll Cardiol; 2013 May; 61(21):2153-60. PubMed ID: 23541971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
    Zareba W; Klein H; Cygankiewicz I; Hall WJ; McNitt S; Brown M; Cannom D; Daubert JP; Eldar M; Gold MR; Goldberger JJ; Goldenberg I; Lichstein E; Pitschner H; Rashtian M; Solomon S; Viskin S; Wang P; Moss AJ;
    Circulation; 2011 Mar; 123(10):1061-72. PubMed ID: 21357819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronisation therapy in patients with heart failure and a normal QRS duration: the RESPOND study.
    Foley PW; Patel K; Irwin N; Sanderson JE; Frenneaux MP; Smith RE; Stegemann B; Leyva F
    Heart; 2011 Jul; 97(13):1041-7. PubMed ID: 21339317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors for restoration of normal left ventricular function in response to cardiac resynchronization therapy measured at time of implantation.
    Serdoz LV; Daleffe E; Merlo M; Zecchin M; Barbati G; Pecora D; Pinamonti B; Fantoni C; Lupo P; Di Lenarda A; Sinagra G; Cappato R
    Am J Cardiol; 2011 Jul; 108(1):75-80. PubMed ID: 21529746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronization therapy in mildly symptomatic heart failure: the earlier the better.
    Balmain S; McDonald MA
    Expert Rev Cardiovasc Ther; 2011 Sep; 9(9):1147-53. PubMed ID: 21932957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cardiac resynchronization therapy on hospitalizations in the Resynchronization-Defibrillation for Ambulatory Heart Failure trial.
    Gillis AM; Kerr CR; Philippon F; Newton G; Talajic M; Froeschl M; Froeschl S; Swiggum E; Yetisir E; Wells GA; Tang AS
    Circulation; 2014 May; 129(20):2021-30. PubMed ID: 24610807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echocardiography and cardiac resynchronization therapy in children and patients with congenital heart disease.
    Mertens L; Friedberg MK
    Minerva Pediatr; 2012 Oct; 64(5):451-60. PubMed ID: 22992528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.